Cardiovascular Systems, Inc.
CSII · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.09 | 2.22 | -0.00 | 49.06 |
| FCF Yield | -5.06% | -0.29% | -1.56% | 0.46% |
| EV / EBITDA | -15.01 | -149.83 | -35.90 | -1,678.08 |
| Quality | ||||
| ROIC | -12.77% | -4.08% | -9.15% | -1.84% |
| Gross Margin | 73.14% | 76.39% | 79.39% | 80.78% |
| Cash Conversion Ratio | 0.66 | 0.07 | 0.47 | -40.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.05% | 1.45% | 2.91% | 6.57% |
| Free Cash Flow Growth | -488.92% | 71.29% | -353.28% | 0.73% |
| Safety | ||||
| Net Debt / EBITDA | 1.34 | 4.71 | 6.45 | 64.56 |
| Interest Coverage | -21.91 | -6.88 | -13.57 | -0.49 |
| Efficiency | ||||
| Inventory Turnover | 1.84 | 1.89 | 1.76 | 2.64 |
| Cash Conversion Cycle | 177.44 | 165.40 | 159.93 | 105.55 |